Pacira Belgium
ActiveSummary
Pacira Belgium has been active since 2020 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €1.9m and a net result of -€1,682. Equity has been stable since 2021 (±1.2% per year). Its solvency ranks better than 64% of 271 sector peers (NACE 72, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Overview
Official details
Source: KBO- Status
- Active since 05-02-2020 Normal situation
- Registered office
- 30 active companies are registered at this address 3 started in the 12 months before. Source: KBO register, as of 2 November 2026.
- Activity
- Research and development on biotechnology NACE 72101
- Establishment unit
- 2.299.292.453 4000 Liège, since 20-02-2020
- Financial year end
- 31 December
- Peppol
- Reachable since 21-12-2025
Financial position
- Bankruptcy probabilitywithin 12 months
- 0.1%
- Gross margin
- €191,089
- ▼ 21.8%
- Turnover
- ≈ €490,000
- estimated
- Loss
- €1,682
- Equity
- €1.9m
- ▼ 0.1%
- Total assets
- €3.0m
- ▲ 4.8%
- Employees on 31-12-2025
- 2
- ▲ 100%
Score breakdownlowers riskFigures for financial year 2025 (filed on 01-07-2026)Size: 1.3 FTE, total assets €3.0mSector: Scientific research and development (NACE 72)Equity €1.9m (64.8% of total assets)Show the evidence
Checked score
About 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 72, micro). It does better than 57% of them on solvency, 19% on liquidity, 34% on profitability and 45% on growth.
The bankruptcy probability was computed on 02-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
The company filed its last 5 accounts on average 36 days before the deadline. In the sector (NACE 72), the median for financial year 2024 was 13 days before the deadline, and 32% of those companies filed late.
Searched, nothing found (2)
Key points
- Positive: Always filed on timeaccounts within the deadline every year 5 years View
Recent changes
- · Gazette deed Company renamed from GQ Bio Therapeutics Belgium to Pacira BelgiumAppointments: RIKER Lauren Bullaro (nicht statutarer verwalter) and MOLLOY Anthony (nicht statutarer verwalter)
- · Gazette deed Company renamed from GeneQuine Biotherapeutics Belgium to GQ Bio Therapeutics Belgium
- · Gazette deed Incorporation
Comparable companies
These companies have the same main activity as Pacira Belgium: research and development on biotechnology (NACE 72101). They are comparable in size and age: total assets between €1m and €6.8m, founded between 2017 and 2022.
| Company | Total assets | Gross margin |
|---|---|---|
| Pacira Belgium Eupen | €3.0m | €0.2m |
| MedImprove Mortsel | €2.3m | €0.6m |
| Abscint Liège | €6.8m | €0.9m |
| QUIDDITAS Liège | €1.2m | €0.2m |
| MY HEALTH INTERNATIONAL Lummen | €1.0m | €0.7m |
| Inhatarget Therapeutics Charleroi | €2.2m | €0.2m |
| SECOYA Technologies Ottignies-Louvain-la-Neuve | €2.3m | €0.3m |
Key facts about Pacira Belgium
- What is the company number of Pacira Belgium?
- The company number of Pacira Belgium is 0742.926.265. The VAT number is the same number with BE in front: BE 0742.926.265.
- Where is Pacira Belgium based?
- The registered office is at Industriestrasse 38, 4700 Eupen.Company details
- What does Pacira Belgium do?
- According to the KBO register, the main activity is research and development on biotechnology (NACE 72101).
- What is the legal form of Pacira Belgium?
- The legal form of Pacira Belgium is Private limited company (BV).
- When was Pacira Belgium founded?
- Pacira Belgium was founded on 05-02-2020.
- Is Pacira Belgium still active?
- Yes, Pacira Belgium is an active enterprise in the KBO register.
- How many employees does Pacira Belgium have?
- Pacira Belgium had an average of 1.3 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
- What is the turnover of Pacira Belgium?
- The turnover in financial year 2025 is ≈ €490,000. This figure is estimated from the gross margin of €191,089 and 1,647 comparable companies of the same size. It probably lies between €300,000 and €910,000. It is a rough estimate.
- Is Pacira Belgium profitable?
- In financial year 2025, Pacira Belgium made a loss of €1,682.
- Where can I find the annual accounts of Pacira Belgium?
- Pacira Belgium filed 5 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of Pacira Belgium due?
- Pacira Belgium must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
See how customers, suppliers and banks see your own company and what to improve first.